Gennex Laboratories 41st AGM: All 4 resolutions passed with over 99.8% majority

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.1%1-day move

₹9.94

prior close

₹9.77

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0+0.3-0.1+0.4+0.5-1.5——————

Up moveDown movePending

AI summary

Gennex Laboratories held its 41st AGM on Sep 30, 2026 via video conferencing. All 4 resolutions passed with requisite majority. Resolution 1 (adoption of audited standalone and consolidated financial statements for FY ended March 31, 2026) got 99.97% support. Resolution 2 (re-appointment of Dr. Avasarala Ranga Rao Pantulu, who retires by rotation) got 99.87%. Resolution 3 (appointment of Mr. Dipankar Dasgupta as Independent Director) got 99.87%. Resolution 4 (ratification of remuneration of cost auditors Sai Krishna and Associates for FY ending March 31, 2027) got 99.87%. About 11.95% of total shares were polled.

Likely market impact

Routine AGM business; all resolutions passed comfortably. No material impact on shareholders expected.